| Synonyms: | |
| Status: | Phase 1 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 276Z913G29 |
| InChI Key | WJRRGYBTGDJBFX-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C18H21N5O2S |
| Molecular Weight | 371.47 |
| AlogP | 3.38 |
| Hydrogen Bond Acceptor | 7.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 5.0 |
| Polar Surface Area | 89.77 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 26.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Cyclin-dependent kinase inhibitor | PubMed |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Kinase
Protein Kinase
CMGC protein kinase group
CMGC protein kinase CDK family
CMGC protein kinase CDC2 subfamily
|
- | 6-6 | - | - | - | |
|
Enzyme
Kinase
Protein Kinase
CMGC protein kinase group
|
- | 6-6 | - | - | - | |
|
Ion channel
Voltage-gated ion channel
Potassium channels
Voltage-gated potassium channel
|
- | 3200 | - | - | - | |
|
Other cytosolic protein
|
- | 16 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Neoplasms | 1 | D009369 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEBI | 91419 |
| ChEMBL | CHEMBL488436 |
| FDA SRS | 276Z913G29 |
| Guide to Pharmacology | 8473 |
| PDB | FB8 |
| PubChem | 16747683 |
| SureChEMBL | SCHEMBL5092360 |
| ZINC | ZINC000040442496 |